Ostrach B - Search Results

1

DEA Disconnect Leads to Buprenorphine Bottlenecks.

Ostrach B, Carpenter D, Cote LP. Ostrach B, et al. J Addict Med. 2021 Jul-Aug 01;15(4):272-275. doi: 10.1097/ADM.0000000000000762. J Addict Med. 2021. PMID: 33181577

2

"I didn't want to be on Suboxone at first…" - Ambivalence in Perinatal Substance Use Treatment.

Ostrach B, Leiner C. Ostrach B, et al. J Addict Med. 2019 Jul/Aug;13(4):264-271. doi: 10.1097/ADM.0000000000000491. J Addict Med. 2019. PMID: 30585875

3

An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic.

Hughes PM, Verrastro G, Fusco CW, Wilson CG, Ostrach B. Hughes PM, et al. Among authors: ostrach b. J Rural Health. 2021 Jun;37(3):467-472. doi: 10.1111/jrh.12570. Epub 2021 Mar 15. J Rural Health. 2021. PMID: 33720447 Free PMC article.

4

Ensuring buprenorphine access in rural community pharmacies to prevent overdoses.

Ostrach B, Potter R, Wilson CG, Carpenter D. Ostrach B, et al. J Am Pharm Assoc (2003). 2022 Mar-Apr;62(2):588-597.e2. doi: 10.1016/j.japh.2021.10.002. Epub 2021 Oct 8. J Am Pharm Assoc (2003). 2022. PMID: 34674965

5

Perinatal OUD Treatment Provider Understandings of Rural Patients' Experiences.

Leiner C, Antono B, Ostrach B. Leiner C, et al. Among authors: ostrach b. J Addict Med. 2022 Mar-Apr 01;16(2):177-182. doi: 10.1097/ADM.0000000000000858. J Addict Med. 2022. PMID: 35289773

6

Rural community pharmacist willingness to dispense Suboxone® - A secret shopper investigation in South-Central Appalachia.

Trull G, Major E, Harless C, Zule W, Ostrach B, Carpenter D. Trull G, et al. Among authors: ostrach b. Explor Res Clin Soc Pharm. 2021 Oct 23;4:100082. doi: 10.1016/j.rcsop.2021.100082. eCollection 2021 Dec. Explor Res Clin Soc Pharm. 2021. PMID: 35479845 Free PMC article.

7

North Carolina community pharmacists' buprenorphine dispensing practices and attitudes.

Carpenter D, Lambert KV, Harless JC, Wilson CG, Davis SA, Zule WA, Ostrach B. Carpenter D, et al. Among authors: ostrach b. J Am Pharm Assoc (2003). 2022 Sep-Oct;62(5):1606-1614. doi: 10.1016/j.japh.2022.04.019. Epub 2022 Apr 30. J Am Pharm Assoc (2003). 2022. PMID: 35643625

8

A content review of buprenorphine training programs for pharmacists.

Davis SA, Dryer R, Zule W, Ostrach B, Carpenter DM. Davis SA, et al. Among authors: ostrach b. Explor Res Clin Soc Pharm. 2022 Jun 24;6:100154. doi: 10.1016/j.rcsop.2022.100154. eCollection 2022 Jun. Explor Res Clin Soc Pharm. 2022. PMID: 35813287 Free PMC article.

9

Increasing North Carolina's Workforce Capacity for Prescribing Buprenorphine Products.

Cabello-De la Garza A, Harless C, Ostrach B, Fagan B. Cabello-De la Garza A, et al. Among authors: ostrach b. N C Med J. 2022 Jul-Aug;83(4):288-293. doi: 10.18043/ncm.83.4.288. N C Med J. 2022. PMID: 35817448 Free article.

10

Factors associated with perceived ease of access to syringes in Appalachian North Carolina.

Carpenter DM, Zule WA, Hennessy CM, Evon DM, Hurt CB, Ostrach B. Carpenter DM, et al. Among authors: ostrach b. J Rural Health. 2023 Jan;39(1):212-222. doi: 10.1111/jrh.12698. Epub 2022 Jul 12. J Rural Health. 2023. PMID: 35819251 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters